Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance, beginning at Sep. 30, 2022	$ 113,655	$ 417,558,434	$ (408,935,518)	$ 8,736,571
Balance, beginning (in shares) at Sep. 30, 2022	11,365,486
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of issuance costs	$ 16,467	30,219,834		30,236,301
Sale of common stock, net of issuance costs (in shares)	1,646,722
Issuance of common stock in connection with conversion of convertible promissory note	$ 6	24,994		25,000
Issuance of common stock in connection with conversion of convertible promissory note (in shares)	625
Stock-based compensation expense		5,547,019		5,547,019
Net Income (Loss)			(58,982,668)	(58,982,668)
Balance, ending at Sep. 30, 2023	$ 130,128	453,350,281	(467,918,186)	(14,437,777)
Balance, ending (in shares) at Sep. 30, 2023	13,012,833
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of issuance costs	$ 92,857			92,857
Sale of common stock, net of issuance costs (in shares)	9,285,709
Issuance of common stock in connection with conversion of convertible promissory note	$ 16,072	11,233,928		11,250,000
Issuance of common stock in connection with conversion of convertible promissory note (in shares)	1,607,093
Stock-based compensation expense		5,385,124		5,385,124
Net Income (Loss)			(75,366,714)	(75,366,714)
Balance, ending at Sep. 30, 2024	$ 239,057	$ 469,969,333	$ (543,284,900)	$ (73,076,510)
Balance, ending (in shares) at Sep. 30, 2024	23,905,635